Blackstone-backed Biomet files for a US IPO that could raise $1 billion

By
A A A

Biomet, an orthopedic products manufacturer and distributor, filed on Monday with the SEC to raise $100 million in an initial public offering, although the deal size is likely just a placeholder. We estimate the company could raise as much as $1 billion. The Warsaw, IN-based company, which was founded in 1977 and booked $3.1 billion in sales for the 12 months ended November 30, 2013, plans to list under the symbol BMET. BofA Merrill Lynch, Goldman Sachs, J.P. Morgan, Citi, Wells Fargo, Barclays and Morgan Stanley are the joint bookrunners on the deal. No pricing terms were disclosed and no exchange was listed.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks:

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Your Car Is Spying on You
Your Car Is Spying on You           

Stocks

Referenced

Most Active by Volume

73,082,014
  • $30.33 ▼ 3.90%
57,046,796
  • $15.52 ▲ 0.45%
51,290,931
  • $100.57 ▲ 0.04%
39,855,468
  • $8.13 ▲ 1.37%
31,693,544
  • $5.50 ▲ 20.35%
31,532,510
  • $10.33 ▲ 0.78%
31,526,753
  • $39.10 ▲ 47.21%
28,366,542
  • $26.36 ▲ 1.19%
As of 8/20/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com